SignaCor
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A UK biotech creating paired diagnostic and therapeutic systems for precision cancer care.
Oncology
Technology Platform
A proprietary platform for discovering tumor-specific biomarkers and developing matched pairs of imaging diagnostics and targeted therapeutics.
Opportunities
Potential for high-value partnerships with large pharma companies seeking to build targeted oncology portfolios.
Risk Factors
Regulatory and development complexity of advancing two distinct products (diagnostic and therapeutic) as a single system.
Competitive Landscape
Competes in the specialized theranostics space against well-established radiopharma giants and other biotechs with similar integrated approaches.